Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma
Liwei Lang(Augusta University), Yong Teng(Augusta University)
Cited by 52
Related Papers
Is It Time to Start Transitioning From 2D to 3D Cell Culture?
|Frontiers in Molecular Biosciences|2020|1.6k
CPI-613 rewires lipid metabolism to enhance pancreatic cancer apoptosis via the AMPK-ACC signaling
|Journal of Experimental & Clinical Cancer Research|2020|138
Combating head and neck cancer metastases by targeting Src using multifunctional nanoparticle-based saracatinib
|Journal of Hematology & Oncology|2018|62
Mediation of PKM2-dependent glycolytic and non-glycolytic pathways by ENO2 in head and neck cancer development
|Journal of Experimental & Clinical Cancer Research|2023|57
Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis
|Journal of Experimental & Clinical Cancer Research|2019|49